🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 9 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/12/1997 | 49,80 | 50,07 | 49,44 | 49,98 | +0,24% | 1,26% | 5.700.282 |
| 05/12/1997 | 49,29 | 49,92 | 48,54 | 49,86 | -0,12% | 2,78% | 9.102.928 |
| 04/12/1997 | 49,38 | 50,10 | 48,90 | 49,92 | +6,76% | 2,42% | 20.388.002 |
| 03/12/1997 | 45,29 | 46,88 | 45,24 | 46,76 | +3,02% | 3,62% | 12.406.853 |
| 02/12/1997 | 45,47 | 45,68 | 45,24 | 45,38 | -0,20% | 0,98% | 8.859.792 |
| 01/12/1997 | 45,32 | 45,50 | 45,21 | 45,47 | +0,51% | 0,66% | 7.230.990 |
| 28/11/1997 | 45,21 | 45,32 | 45,12 | 45,24 | +0,75% | 0,46% | 1.564.664 |
| 26/11/1997 | 44,85 | 45,21 | 44,70 | 44,91 | +0,20% | 1,13% | 4.857.061 |
| 25/11/1997 | 44,67 | 45,06 | 44,31 | 44,82 | +1,55% | 1,67% | 7.926.862 |
| 24/11/1997 | 44,79 | 45,00 | 43,71 | 44,13 | -2,18% | 2,86% | 7.191.586 |
| 21/11/1997 | 44,13 | 45,18 | 43,62 | 45,12 | +2,16% | 3,51% | 10.782.872 |
| 20/11/1997 | 44,76 | 45,41 | 44,13 | 44,16 | -0,27% | 2,86% | 8.195.779 |
| 19/11/1997 | 43,24 | 44,64 | 43,15 | 44,28 | +2,41% | 3,45% | 5.433.042 |
| 18/11/1997 | 43,54 | 44,01 | 43,12 | 43,24 | -0,82% | 2,05% | 5.189.067 |
| 17/11/1997 | 43,42 | 43,98 | 43,39 | 43,59 | +1,18% | 1,37% | 7.359.266 |
| 14/11/1997 | 41,95 | 43,24 | 41,90 | 43,09 | +2,70% | 3,20% | 7.746.606 |
| 13/11/1997 | 41,81 | 42,10 | 40,70 | 41,95 | +1,15% | 3,35% | 9.136.883 |
| 12/11/1997 | 41,98 | 42,64 | 41,15 | 41,48 | -1,90% | 3,55% | 8.064.360 |
| 11/11/1997 | 42,13 | 42,82 | 42,13 | 42,28 | +0,14% | 1,63% | 5.512.690 |
| 10/11/1997 | 42,94 | 43,18 | 42,10 | 42,22 | -0,28% | 2,50% | 7.219.462 |
| 07/11/1997 | 41,75 | 42,67 | 41,57 | 42,34 | +0,00% | 2,64% | 8.690.854 |
| 06/11/1997 | 42,04 | 42,64 | 41,93 | 42,34 | +1,00% | 1,70% | 7.463.646 |
| 05/11/1997 | 41,98 | 42,31 | 41,57 | 41,93 | -0,35% | 1,78% | 8.598.630 |
| 04/11/1997 | 43,06 | 43,24 | 42,04 | 42,07 | -2,56% | 2,77% | 6.506.822 |
| 03/11/1997 | 43,15 | 43,36 | 42,70 | 43,18 | +1,40% | 1,52% | 6.624.408 |
| 31/10/1997 | 42,28 | 42,88 | 41,84 | 42,58 | +2,00% | 2,47% | 6.688.546 |
| 30/10/1997 | 41,98 | 43,15 | 38,47 | 41,75 | -1,34% | 11,15% | 7.623.152 |
| 29/10/1997 | 42,64 | 43,33 | 42,04 | 42,31 | +0,92% | 3,01% | 11.973.819 |
| 28/10/1997 | 39,12 | 42,94 | 39,12 | 41,93 | +3,38% | 9,76% | 23.196.432 |
| 27/10/1997 | 43,18 | 43,21 | 40,55 | 40,55 | -8,97% | 6,15% | 16.099.586 |